Multiple Sclerosis News and Research RSS Feed - Multiple Sclerosis News and Research

Hyaluronidase enzyme may be effective treatment option for spasticity caused by neurological injury

Hyaluronidase enzyme may be effective treatment option for spasticity caused by neurological injury

A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling condition in people who have had a stroke or other brain injury. [More]
National Multiple Sclerosis Society calls for change to make MS drugs accessible

National Multiple Sclerosis Society calls for change to make MS drugs accessible

When Abigail Bostwick, 36, was diagnosed with multiple sclerosis in 2013, she never thought it would hit her as hard as it has -- not physically -- but financially. [More]
microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions is hosting two compact digital pathology webinars back to back on Oct 11th. [More]
Color-deficiency or color-blindness?

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors. [More]
Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology. [More]
TSRI scientists shed light on molecular workings of MS drug

TSRI scientists shed light on molecular workings of MS drug

A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious. [More]
ECTRIMS, EAN collaborate to develop new therapeutic guidelines for MS

ECTRIMS, EAN collaborate to develop new therapeutic guidelines for MS

The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (MS) concluded today in London (September 14-17) and one of the late breaking sessions presented the Clinical Guideline on the pharmacological management of people with Multiple Sclerosis developed jointly by ECTRIMS and European Academy of Neurology (EAN). [More]
Study suggests interactions between distant DNA regions may impact disease gene levels

Study suggests interactions between distant DNA regions may impact disease gene levels

A person's DNA sequence can provide a lot of information about how genes are turned on and off, but new research out of Case Western Reserve University School of Medicine suggests the 3-D structure DNA forms as it crams into cells may provide an additional layer of gene control. [More]
Researchers find switch that helps restore damaged axons

Researchers find switch that helps restore damaged axons

Researchers at the University of Wisconsin-Madison have found a switch that redirects helper cells in the peripheral nervous system into "repair" mode, a form that restores damaged axons. [More]
ECTRIMS 2016: Young investigator explains new MRI criteria for MS diagnosis in patients with CIS

ECTRIMS 2016: Young investigator explains new MRI criteria for MS diagnosis in patients with CIS

The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis opened yesterday in London (September 14-17) and key presentations reveal the latest evidence-based thinking on how to use MRI scan results to diagnose MS with increasing accuracy. [More]
Women, minorities less likely to receive stroke treatment, study finds

Women, minorities less likely to receive stroke treatment, study finds

Women and minorities may be less likely to receive treatment for stroke, according to a study published in the September 14, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]
Research findings may pave way for innovative treatments of multiple sclerosis

Research findings may pave way for innovative treatments of multiple sclerosis

Researchers at the Research Center for Immunotherapy and the Focus Program Translational Neurosciences of Johannes Gutenberg University Mainz have identified a new mechanism that is involved in the development of autoimmune diseases. [More]
Researchers develop method to predict disease activity in multiple sclerosis

Researchers develop method to predict disease activity in multiple sclerosis

Cells in the immune system of patients with multiple sclerosis behave differently from those of healthy individuals. Researchers at Linköping University in Sweden have exploited this difference to develop a method that can predict disease activity in multiple sclerosis. [More]
Triptolide molecule can turn into 'cruise missile' against cancer

Triptolide molecule can turn into 'cruise missile' against cancer

More than 20 years ago, a billboard in China piqued the interest of a chemical biologist. It endorsed an extract from the plant known as the “thunder god vine” as an immunosuppressant. [More]
Different types of stroke have diverse risk profiles in overweight or obese women

Different types of stroke have diverse risk profiles in overweight or obese women

According to new research, women who are overweight or obese may have an increased risk of the most common kind of stroke, called ischemic stroke, but a decreased risk of a more often deadly stroke, called hemorrhagic stroke. [More]
Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

CUBRIC is one of the top neuroimaging research centres in the UK and has grown rapidly since it opened in 2006. CUBRIC is expected to become an international hub for neuroimaging, unique in Europe. [More]
Scientists developing virtual reality-based early diagnosis system for neurodegenerative disorders

Scientists developing virtual reality-based early diagnosis system for neurodegenerative disorders

Scientists from Tomsk Polytechnic University and Siberian State Medical University are developing an early diagnosis system for neurodegenerative disorders. [More]
Taking two new epilepsy drugs during pregnancy may not harm thinking skills and IQs of children

Taking two new epilepsy drugs during pregnancy may not harm thinking skills and IQs of children

Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study. [More]
Study highlights possible reasons for MS misdiagnosis

Study highlights possible reasons for MS misdiagnosis

A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S in a study published online August 31, 2016 in the journal Neurology. [More]
People with migraine feel isolated, stigmatized and often dissatisfied with treatment, survey reveals

People with migraine feel isolated, stigmatized and often dissatisfied with treatment, survey reveals

Migraine in America 2016, a national survey by Health Union of more than 3,900 individuals experiencing migraines, reveals that patients have numerous treatment options, but are often dissatisfied with results. [More]
Advertisement
Advertisement